alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 19,926–19,950 of 27,380 studies, newest first · page 798 of 1096.

September 2011 25

  1. 2011-09-14

    Brain amyloid imaging

    ✓ Peer-reviewed Brain scans and imaging Journal of nuclear medicine : official publication, Society of Nuclear Medicine

    Key finding: Imaging of brain β-amyloid plaques with (18)F-labeled tracers for PET will likely be available in clinical practice to assist the diagnosis of Alzheimer disease (AD). +3 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2011-09-14

    A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease

    ✓ Peer-reviewed Treatments Neurology

    Key finding: Primary clinical efficacy outcomes were not significant. +4 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2011-09-14

    Chronic divalproex sodium use and brain atrophy in Alzheimer disease

    ✓ Peer-reviewed Genetics Neurology

    Key finding: There were no baseline differences between active treatment and placebo groups in age, education, brain volumes, clinical rating scores, or APOE ε4 carrier status. +2 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2011-09-13

    Differences in Mortality Associated with Dementia in U.S. Blacks and Whites

    ✓ Peer-reviewed Risk factors Journal of the American Geriatrics Society

    Key finding: From 1999 to 2004, the U.S. age-adjusted annual death rate per 100,000 for dementia was 628 in blacks and 647 in whites. +4 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2011-09-12

    Reshaping the mind: The benefits of bilingualism

    ✓ Peer-reviewed Risk factors Canadian Journal of Experimental Psychology/Revue canadienne de psychologie expérimentale

    Key finding: Studies have shown that bilingual individuals consistently outperform their monolingual counterparts on tasks involving executive control.

    Full summary, score breakdown and related studies → Original source

  6. 2011-09-12

    Physics strategies for sparing neural stem cells during whole-brain radiation treatments

    ✓ Peer-reviewed Health systems and care delivery Medical Physics

    Key finding: The plans are all normalized such that 50% of the PTV receives 30 Gy. +4 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2011-09-12

    Autosomal recessive causes likely in early-onset Alzheimer disease

    ✓ Peer-reviewed Brain tissue and pathology Archives of neurology

    Key finding: A liability threshold model of disease was used to estimate heritability of EOAD and late-onset Alzheimer disease (AD) using concordance for AD among parent-offspring pairs. +3 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2011-09-12

    Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial

    ✓ Peer-reviewed Treatments Archives of neurology

    Key finding: Outcome measures were analyzed using repeated-measures analysis of covariance. +1 more finding

    Full summary, score breakdown and related studies → Original source

  9. 2011-09-09

    Large-scale brain networks and psychopathology: a unifying triple network model

    ✓ Peer-reviewed Risk factors Trends in cognitive sciences

    Key finding: The science of large-scale brain networks offers a powerful paradigm for investigating cognitive and affective dysfunction in psychiatric and neurological disorders. +4 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2011-09-09

    Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using β-amyloid imaging

    ✓ Peer-reviewed Brain scans and imaging Brain : a journal of neurology

    Key finding: The semantic and non-fluent/agrammatic variants are largely associated with frontotemporal lobar degeneration with TDP-43 and tau pathology, respectively. +2 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2011-09-08

    Neuronal death induced by nanomolar amyloid β is mediated by primary phagocytosis of neurons by microglia

    ✓ Peer-reviewed Inflammation and the immune system The Journal of biological chemistry

    Key finding: Although high concentrations of Aβ (μM) can induce direct toxicity to neurons, we find that low concentration (nM) induce neuronal loss through a microglia-mediated mechanism. +3 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2011-09-08

    Transient cognitive impairment in TIA and minor stroke

    ✓ Peer-reviewed Cognitive tests and assessment Stroke

    Key finding: Acute cognitive impairment and delirium occur after major stroke and are associated with poor cognitive outcome. +3 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2011-09-08

    Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4

    ✓ Peer-reviewed Drug development Age (Dordrecht, Netherlands)

    Key finding: Several physiopathological features including hyperglycemia, oxidative stress, and dysfunctional insulin signaling relate DM to AD. +3 more findings

    Full summary, score breakdown and related studies → Original source

  14. 2011-09-07

    Modeling familial Alzheimer's disease with induced pluripotent stem cells

    ✓ Peer-reviewed Risk genes beyond APOE Human Molecular Genetics

    Key finding: Our findings demonstrate that the FAD-iPSC-derived neuron is a valid model of AD and provides an innovative strategy for the study of age-related neurodegenerative diseases.

    Full summary, score breakdown and related studies → Original source

  15. 2011-09-07

    A pathophysiological framework of hippocampal dysfunction in ageing and disease

    ✓ Peer-reviewed Risk factors Nature reviews. Neuroscience

    Key finding: Recent neuroimaging findings indicate that these disorders differentially target distinct subregions of the hippocampal circuit. +1 more finding

    Full summary, score breakdown and related studies → Original source

  16. 2011-09-07

    Advanced glycation end product level, diabetes, and accelerated cognitive aging

    ✓ Peer-reviewed Disease mechanisms Neurology

    Key finding: High peripheral AGE level is associated with greater cognitive decline in older adults with and without diabetes. +4 more findings

    Full summary, score breakdown and related studies → Original source

  17. 2011-09-06

    The interplay of cholinergic function, attention, and falls in Parkinson's disease

    ✓ Peer-reviewed Clinical safety Movement disorders : official journal of the Movement Disorder Society

    Key finding: Both these structures undergo degeneration in Parkinson's disease (PD), with more severe loss associated with cognitive impairment. +3 more findings

    Full summary, score breakdown and related studies → Original source

  18. 2011-09-06

    Neural language networks at birth

    ✓ Peer-reviewed Lewy body dementia Proceedings of the National Academy of Sciences of the United States of America

    Key finding: In adults and children, brain imaging studies have shown that auditory language activates a bilateral frontotemporal network with a left hemispheric dominance.

    Full summary, score breakdown and related studies → Original source

  19. 2011-09-06

    The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease

    ✓ Peer-reviewed Getting a diagnosis Neurobiology of learning and memory

    Key finding: These findings have established the oligomer hypothesis as a new molecular basis for the cause, diagnosis, and treatment of AD.

    Full summary, score breakdown and related studies → Original source

  20. 2011-09-06

    Effect of second-generation antipsychotics on caregiver burden in Alzheimer's disease

    ✓ Peer-reviewed Treatments The Journal of clinical psychiatry

    Key finding: In AD patients with symptoms of psychosis, agitation, or aggressive behavior, medications can have a small but significant impact on caregiver burden. +3 more findings

    Full summary, score breakdown and related studies → Original source

  21. 2011-09-03

    Parkinsonism and frontotemporal dementia: the clinical overlap

    ✓ Peer-reviewed Digital health tools Journal of molecular neuroscience : MN

    Key finding: Frontotemporal dementia is commonly associated with parkinsonism in several sporadic (i.e., progressive supranuclear palsy, corticobasal degeneration) and familial neurodegenerative disorders (i.e., frontotemporal dementia associated with parkinsonism and MAPT or progranulin mutations in chromosome 17).

    Full summary, score breakdown and related studies → Original source

  22. 2011-09-01

    Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation

    ✓ Peer-reviewed Risk factors Neuron

    Key finding: NOS2 deficiency or oral treatment with the NOS2 inhibitor L-NIL strongly decreased 3NTyr(10)-Aβ, overall Aβ deposition and cognitive dysfunction in APP/PS1 mice.

    Full summary, score breakdown and related studies → Original source

  23. 2011-09-01

    Purinergic signalling: from normal behaviour to pathological brain function

    ✓ Peer-reviewed Risk factors Progress in neurobiology

    Key finding: They mediate both fast signalling in neurotransmission and neuromodulation and long-term (trophic) signalling in cell proliferation, differentiation and death. +4 more findings

    Full summary, score breakdown and related studies → Original source

  24. 2011-09-01

    Cholinesterases, a target of pharmacology and toxicology

    ✓ Peer-reviewed Treatments Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia

    Key finding: The crucial role of the cholinesterases in neural transmission makes them a primary target of a large number of cholinesterase-inhibiting drugs and toxins.

    Full summary, score breakdown and related studies → Original source

  25. 2011-09-01

    Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis

    ✓ Peer-reviewed Vascular contributions JAMA

    Key finding: Among 14 placebo-controlled trials of elderly patients with dementia reporting a total global outcome score that includes symptoms such as psychosis, mood alterations, and aggression, small but statistically significant effects sizes ranging from 0.12 and 0.20 were observed for aripiprazole, olanzapine, and risperidone. +4 more findings

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →